OverviewZogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$10.80 + 0.20
Data as of 04/25/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Investor Events More
Wednesday, March 22, 2017 2:10 p.m. ET
Zogenix, Inc. at Oppenheimer 27th Annual Healthcare Conference
Thursday, March 9, 2017 4:30 p.m. ET
Q4 2016 Zogenix, Inc. Earnings Conference Call